As clinicians and researchers continue to advance their understanding of adult growth hormone deficiency (AGHD), knowing who is at risk for developing AGHD and how they will respond to therapy grows ever more important.
So, who is at risk for AGHD? What are the recommended diagnostic tools? How does growth hormone replacement therapy (GHRT) affect patients? Take our 6-question quiz on a few facts and some emerging evidence.
1. Patients should be tested for AGHD if there is evidence of hypothalamic-pituitary disease or related trauma, and in instances where there is an intention to treat with growth hormone.
- Boguszewski CL. Update on GH therapy in adults. F1000Res. 2017; doi:10.12688/f1000research.12057.1.
- Molitch ME, Clemmons DR, Malozowski S, et al. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1587–609. 10.1210/jc.2011-0179